SEC Reviewing Apple's (AAPL) Disclosures About Jobs' Health

According to reports from Bloomberg, Apple's (Nasdaq: AAPL) disclosures about the health of its CEO Steve Jobs is under scrutiny by the SEC. The SEC is looking at how Jobs' condition went from "relatively simple" to "more complex" in nine days, a person familiar with the matter said.

A question regulators want to know is what Apple's board knew at the time of Jobs' Jan 5 announcement that he had a hormone imbalance and a Jan 14 statement the we was taking a five-and-a-half month medical leave.

Jobs went on to have a liver transplant during the leave.

The SEC review doesn't mean the agency will accuse Jobs or the company of wrongdoing.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• Light & Wonder to report Q2 results Aug. 4, reaffirms FY26 outlook
• Elong Power closes $6.6M public offering on Nasdaq